Cold & Cough Remedies (Pharmacies) - France

Revenue in the Cold & Cough Remedies market is projected to reach US$581.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.31%, resulting in a market volume of US$685.00m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$8.97 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in France is experiencing steady growth due to various factors.

Customer preferences: Customers in France are increasingly seeking over-the-counter remedies for cold and cough symptoms. This trend can be attributed to several factors. Firstly, the convenience of purchasing these remedies directly from pharmacies appeals to busy consumers who prefer not to visit a doctor for minor ailments. Additionally, the increasing awareness of self-care and the desire for immediate relief are driving customers to seek remedies that can be easily accessed without a prescription.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in France is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for remedies that are perceived to be safer and have fewer side effects. This trend is also influenced by the rising popularity of alternative medicine and the belief in the healing properties of natural ingredients. Another trend in the market is the increasing availability and variety of cold and cough remedies. Pharmacies in France are expanding their product offerings to cater to the diverse needs and preferences of customers. This includes a wider range of formulations, such as syrups, tablets, and nasal sprays, as well as products targeting specific symptoms, such as sore throat or nasal congestion. The availability of these options allows customers to choose remedies that best suit their individual needs.

Local special circumstances: France has a strong pharmaceutical industry and a well-established healthcare system, which contributes to the growth of the Cold & Cough Remedies (Pharmacies) market. The country has a high number of pharmacies, ensuring easy access to these products for consumers. Additionally, the French government has implemented policies to promote self-medication and encourage the use of over-the-counter remedies, further driving the demand in the market.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in France is also influenced by macroeconomic factors. The country has a stable economy and a high standard of living, allowing consumers to afford these remedies. Additionally, the aging population in France is contributing to the growth of the market, as older individuals are more prone to cold and cough symptoms and are more likely to seek remedies to alleviate their discomfort. In conclusion, the Cold & Cough Remedies (Pharmacies) market in France is experiencing steady growth due to customer preferences for over-the-counter remedies, the availability of natural and herbal options, the expanding product offerings in pharmacies, the strong pharmaceutical industry and healthcare system in the country, and the underlying macroeconomic factors such as a stable economy and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.